No abstract

Stage IV periodontitis is characterized by severe periodontal attachment loss, vertical bone loss and pathologic tooth migration (PTM) (Brunsvold, 2005), requiring complex rehabilitation due to masticatory dysfunction, secondary occlusal trauma, bite collapse, and drifting and flaring of the remaining teeth (Papapanou et al. 2018;Tonetti & Sanz, 2019). Many patients affected by such a condition are interested in orthodontic treatment because of the aesthetic and functional changes caused by PTM, as shown by a recent survey (Hirschfeld et al. 2019). If the periodontal inflammation remains uncontrolled during the orthodontic treatment this will accelerate the progression of periodontal destruction leading to further loss of attachment (Wennström et al., 1993). An interdisciplinary approach is therefore required to control the periodontal infection, reconstruct the defects and realign the migrated teeth

Within the limits of the retrospective study design, the findings indicate that periodontal treatment using DBBMc with or without CM or EMD can lead to long-term defect reduction and tooth survival for up to 10 years in the setting of a periodontal practice.

Both SAPM gel and ACC toothpaste were successful in providing relief from DHS and showed similar outcomes on VAS and verbal response scale (VRS) throughout the study period of 90 days. The new therapeutic regimen using SAPM resulted in higher patient satisfaction at day 7, as indicated by the patient questionnaire and the higher number of pain-free patients at day 7 and day 90. This is a pilot study describing a novel therapy for DHS.

This case report demonstrates the practicability of the biocompatible galvanoforming procedure for implant-supported restorations enhancing periodontal response and esthetics.